Understanding how certain receptors are activated to develop new therapies
CONTROL AND ACTIVATION OF THE TUMOR NECROSIS FACTOR RECEPTORS
This study is looking at how certain receptors in the body work, which could help create better antibody treatments for autoimmune diseases and other related conditions.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Harvard Medical School NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10764799 on NIH RePORTER |
What this research studies
This research investigates the activation mechanisms of tumor necrosis factor receptors, which are important targets for antibody-based therapies. By studying how these receptors cluster and signal, the researchers aim to develop more effective therapeutic antibodies that can either activate or inhibit these receptors. The approach includes structural and functional studies to understand the role of receptor components in their activation. This could lead to more precise treatments for autoimmune diseases and other conditions related to these receptors.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with autoimmune diseases or conditions that involve tumor necrosis factor receptors.
Not a fit: Patients with conditions unrelated to tumor necrosis factor receptors or those not affected by autoimmune diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective and targeted therapies for autoimmune diseases and other conditions.
How similar studies have performed: Previous research has shown promise in targeting tumor necrosis factor receptors for therapeutic development, indicating that this approach has potential for success.
Where this research is happening
Boston, United States
- Harvard Medical School — Boston, United States (Active)
Researchers
- Principal investigator: Wagner, Gerhard — Harvard Medical School
- Study coordinator: Wagner, Gerhard
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.